Dow drops 400 points as Procter & Gamble misses Q4 sales estimates
The Dow Jones Industrial Average fell over 400 points to 52,334.00, driven by Procter & Gamble's 4% share price drop after missing Q4 sales estimates of $21.379 billion with actuals of $21.203 billion. Despite beating EPS estimates, weak FY27 guidance weighed on sentiment. Energy stocks rose 3%, while oil jumped 6.4% to $84.35.

*this image is generated using AI for illustrative purposes only.
U.S. equities traded lower on Wednesday, led by a sharp decline in the Dow Jones Industrial Average, which fell more than 400 points to close at 52,334.00, down 0.78%. The broader market weakness was anchored by Procter & Gamble Co (NYSE: PG), whose shares dropped approximately 4% following the release of fourth-quarter results that disappointed investors on revenue and forward guidance.
Procter & Gamble reported quarterly sales of $21.203 billion, missing the analyst consensus estimate of $21.379 billion. Although the company delivered quarterly earnings of $1.43 per share, beating the consensus estimate of $1.41 per share, the stock sold off after management issued fiscal year 2027 GAAP earnings-per-share guidance that came in below analyst expectations.
Market Overview
The decline in the Dow Jones was accompanied by modest losses across other major benchmarks. The NASDAQ Composite declined 0.02% to close at 24,872.92, while the S&P 500 index fell 0.04% to 7,426.03.
Sector performance was mixed, with energy shares emerging as the day’s top performer, jumping by 3%. In contrast, industrials stocks continued their downward trend from Tuesday, falling by an additional 1.1% on Wednesday.
Top Movers
Several equities saw significant volatility amid the broader market sell-off. Autonomix Medical Inc (NASDAQ: AMIX) surged 117% to $5.96, while Nocera Inc (NASDAQ: NCRA) rose 113% to $3.04 after announcing the acquisition of a 30% interest in QMAX Technology. Star Fashion Culture Holdings Ltd (NASDAQ: STFS) also gained significantly, rising 53% to $5.57.
On the downside, AiRWA Inc (NASDAQ: YYAI) plummeted 49% to $0.45. Processa Pharmaceuticals Inc (NASDAQ: PCSA) fell 33% to $2.03 following announcements of a $200 million private placement and the acquisition of Vidya Therapeutics BTK Inhibitor VT-7208. Parsons Corp (NYSE: PSN) also declined 33% to $41.42 after reporting worse-than-expected second-quarter sales and cutting its fiscal year 2026 sales guidance.
Commodities and Global Markets
In commodity trading, oil prices rose sharply, up 6.4% to $84.35. Precious metals faced headwinds, with gold falling 0.7% to $4,011.50, silver down 0.2% to $57.410, and copper declining 0.6% to $6.3220.
Global equity markets showed mixed results. European indices were largely flat or negative, with the STOXX 600 falling 0.1%, France’s CAC 40 dropping 0.6%, and Spain’s IBEX 35 declining 1.3%. London’s FTSE 100 rose 0.3%, while Germany’s DAX gained 0.2%. Asian markets closed mixed, with Japan’s Nikkei 225 dipping 1.49%, offset by gains in Hong Kong’s Hang Seng Index (+1.96%), China’s Shanghai Composite (+0.40%), and India’s BSE Sensex (+1.2%).
Economic Data
In economic news, the volume of mortgage applications declined by 6.4% from the previous week, for the week ending July 24.
How might Procter & Gamble's weaker-than-expected FY2027 guidance signal broader consumer spending fatigue, and which other consumer staples stocks are likely to face similar pressure?
Given the sharp 6.4% surge in oil prices alongside rising energy sector performance, is this rally driven by supply constraints or geopolitical risks, and how will it impact inflation expectations?
With mortgage application volumes dropping 6.4%, what does this suggest about the resilience of the U.S. housing market in the coming quarters despite recent rate stability?

































